StockPriceToday
SuRo Capital Corp. (SSSS)
About SuRo Capital Corp.
SuRo Capital Corp., formerly GSV Capital, repositioned itself as an investment company focused on providing public market access to high-growth private companies typically available only to institutional venture capital investors. The company seeks to bridge the gap between private and public markets. SSSS stock price reflects both the performance of underlying portfolio companies and investor demand for venture capital exposure.
Under the leadership of CEO Mark Klein, SuRo Capital has focused on building a portfolio of late-stage venture-backed companies with established business models and clear paths to profitability or public offerings. The management team brings venture capital and public markets experience to investment selection and portfolio management. Leadership's strategic approach to providing liquidity and transparency in private market investments has been important for differentiating the investment approach and influencing SSSS stock price performance.
SuRo Capital operates by investing in late-stage private companies across technology, healthcare, and other high-growth sectors, providing shareholders exposure to venture capital returns through a publicly traded vehicle. The company generates returns through capital appreciation and eventual liquidity events including IPOs and acquisitions. With continued innovation in technology and healthcare creating venture capital opportunities, increasing interest in private market access among retail investors, and SuRo Capital's unique positioning bridging private and public markets, SSSS offers investors alternative exposure to venture capital with liquidity advantages, though private company valuations and exit timing create inherent volatility and performance uncertainty.
SSSS Stock 12 Month Chart
Latest News for SSSS
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital” or the “Company”) ( NASDAQ: SSSS) the first publicly traded venture fund, announced today that it will ring the NASDAQ ...
Other Popular Stocks
Aclaris Therapeutics Inc. is a clinical-stage biotechnology company developing therapies for dermatological and rheumatological conditions.
Cipher Mining Inc. (CIFRW) warrants represent the right to purchase shares of Cipher Mining common stock at a predetermined exercise price, providing leveraged exposure...
IDEAYA Biosciences Inc. (IDYA) is a biotechnology company focused on discovering and developing precision medicine oncology therapeutics targeting tumor vulnerabilities.